Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Julia T. Warren, Kelly J. Walkovich, Audrey Anna Bolyard, Kathryn E. Dickerson, Jolan E. Walter, Diego Cadavid, Eloisa Chapa, Kelly Chen, Richard MacLeod, Katie Peters, Richard Polisson, David C. Dale
Institutions: Washington University in St. Louis, University of Michigan, University of Washington, The University of Texas Southwestern Medical Center, Johns Hopkins University, University of South Florida, Massachusetts General Hospital, Johns Hopkins All Children's Hospital, X4 Pharmaceuticals, Inc. (United States)
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4310107097